Autoimmunity Reviews

Papers
(The H4-Index of Autoimmunity Reviews is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)
ArticleCitations
Aquaporins: Unexpected actors in autoimmune diseases390
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases254
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome202
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study202
Editorial Board165
Diagnostic approach in giant cell arteritis140
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders123
Editorial Board105
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis103
Cardiovascular disease risk in systemic lupus erythematous: Certainties and controversies91
Rituximab-induced cystoid macular edema in a patient with systemic lupus erythematosus: A case report and literature review81
Human mesenchymal stem cells for the management of systemic sclerosis. Systematic review81
Editorial Board81
Inflammatory muscle involvement in systemic vasculitis: A systematic review73
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases68
Current landscape of monogenic autoinflammatory actinopathies: A literature review64
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis61
Genetic and genomic associations in antiphospholipid syndrome: A systematic review61
“Fibromyalgia syndrome” related to Essure devices55
Isoprostanes in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review and meta-analysis54
Antiphospholipid antibodies and COVID-1954
Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review52
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence52
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis50
Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge49
Molecular mimicry between SARS-CoV-2 and human proteins48
Editorial Board48
TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review48
Persistent aortic inflammation in patients with giant cell arteritis48
Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?45
Should we use nintedanib as early therapy in patients with SSc-ILD?44
Rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis triggered by a 23-valent pneumococcal polysaccharide vaccine43
Leflunomide: A safe and effective alternative in systemic lupus erythematosus43
Editorial Board43
Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response42
Sjögren's Syndrome: an undiagnosed etiology for facial pain Case series with review of neurological manifestation of Sjögren syndrome42
From inflammation to renal fibrosis: A one-way road in autoimmunity?41
Editorial Board41
JAK inhibitors and systemic sclerosis: A systematic review of the literature38
Non-pharmacological interventions in the treatment of rheumatoid arthritis: A systematic review and meta-analysis38
Undifferentiated connective tissue disease at risk for systemic sclerosis: Development of a short-term predictive score and a risk stratification tool38
0.20249605178833